Latest News


New FDA Approval for Taiho Oncology, Inc

Taiho Oncology, Inc., is pleased to inform you that the “FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC),” has been issued on Aug. 2, 2023.


NPPES and the NPI Registry

Many of you have noted the recent instability of NPPES and the NPI Registry. CMS has begun implementing changes that should eliminate the instability. We expect that these changes will be completed next week.

News & Events